Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Cash and cash equivalents	$ 434,787	$ 50,986
Short-term receivables - legal fees, settlement and other, net	290,076	595,326
Prepaid expenses	169,113	370,209
Total Current Assets	893,976	1,016,521
Equipment and furnishings, less accumulated depreciation of $61,107 and $50,538, respectively	61,907	72,476
Operating lease right-of-use asset	212,187
Patents, net of accumulated amortization of $11,319,558 and $10,816,218, respectively	395,887	899,227
Total Assets	1,563,957	1,988,224
Current Liabilities:
Accounts payable - trade	1,345,677	3,312,049
Other accrued expenses	949,427	790,358
Current portion of operating lease liability	76,423
Total Current Liabilities	2,371,527	4,102,407
Accrued interest	1,314,357	659,379
Accrued interest - related parties	1,125,549	711,927
Convertible notes payable	12,297,000	7,062,000
Convertible notes payable - related parties	6,895,000	6,870,000
Non-current portion of operating lease liability	148,644
Total Liabilities	24,152,077	19,405,713
Commitments and contingencies (Note 8)
Stockholders' Deficiency:
Preferred stock; par value $0.001 per share; 25,000,000 shares authorized; Series B Convertible Preferred Stock; 240,000 shares designated; 100 shares issued and outstanding at September 30, 2019 and December 31, 2018; aggregate liquidation preference of $3,500 at September 30, 2019 and December 31, 2018
Common stock; par value $0.001 per share; 1,000,000,000 shares authorized; 388,576,975 and 384,614,528 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively	388,577	384,615
Additional paid-in capital	209,309,619	209,092,187
Accumulated other comprehensive loss	(24,801)
Accumulated deficit	(232,261,515)	(226,894,291)
Total Stockholders' Deficiency	(22,588,120)	(17,417,489)
Total Liabilities and Stockholders' Deficiency	$ 1,563,957	$ 1,988,224